Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017.SR) — Cash flow
Operating, investing, and financing cash flow for Dr. Soliman Abdul Kader Fakeeh Hospital Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 290↑1.1% | 287↑12.7% | 255↓21.9% | 326↓2.4% | 334 | |
| Depreciation & Amortization | 182↑11.9% | 163↑9.0% | 149↑36.6% | 109↑4.1% | 105 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -26↓237.8% | 19↑113.0% | -144↑75.1% | -578↓90.7% | -303 | |
| Accounts Receivable | -75↑51.5% | -155↓66.5% | -93↑49.8% | -185↓273.9% | -50 | |
| Inventory | -18↓12.6% | -16↑50.7% | -32↓402.1% | -6↓64.2% | -4 | |
| Accounts Payable | -11 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Working Capital | 78↓59.0% | 189↑1071.5% | -19↑95.0% | -387↓54.8% | -250 | |
| Other Non-Cash Items | 25↑177.5% | -33↓4.0% | -31↓124.5% | 128↑7.9% | 118 | |
| Net Cash from Operating Activities | 472↑8.2% | 436↑90.8% | 229↑1662.9% | -15↓105.7% | 255 | |
| Operating Cash Flow | 472↑8.2% | 436↑90.8% | 229↑1662.9% | -15↓105.7% | 255 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -529↓2.3% | -518↓39.0% | -372↓201.3% | -124↓54.4% | -80 | |
| Capital Expenditure | -520↑0.9% | -525↓39.4% | -377↓204.6% | -124↓54.4% | -80 | |
| Acquisitions | 87 | 0.00 | 0.00↑100.0% | -262 | 0.00 | |
| Purchases of Investments | -99↑49.3% | -196 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | -7↓171.9% | 10↓99.3% | 1,385↑134899.7% | 1↑105.0% | -21 | |
| Net Cash from Investing Activities | -549↑21.9% | -703↓169.4% | 1,013↑363.5% | -384↓281.8% | -101 | |
| Financing Activities | ||||||
| Net Debt Issuance | 95↑108.0% | -1,184↓832.1% | -127↓467.6% | 35↑127.3% | -127 | |
| Long-Term Net Debt Issuance | 13↑101.4% | -905↓1250.3% | -67↓294.0% | 35↑127.3% | -127 | |
| Short-Term Net Debt Issuance | 83↑129.6% | -279↓364.8% | -60 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00↓100.0% | 1,683 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00↓100.0% | 1,683 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00↓100.0% | 1,683 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -69 | 0.00↑100.0% | -1,150↓3185.7% | -35↓54.9% | -23 | |
| Common Dividends Paid | -69 | 0.00↑100.0% | -1,150↓3185.7% | -35↓54.9% | -23 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -43↓149.6% | 88↑231.1% | -67↓112.7% | 525↑300441.8% | -0.17 | |
| Net Cash from Financing Activities | -17↓103.0% | 587↑143.7% | -1,344↓356.4% | 524↑450.5% | -150 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -95↓129.6% | 319↑411.8% | -102↓181.9% | 125↑2701.5% | 4 | |
| Cash at Beginning of Period | 534↑149.1% | 214↓32.3% | 317↑65.3% | 192↑2.4% | 187 | |
| Cash at End of Period | 439↓17.7% | 534↑149.1% | 214↓32.3% | 317↑65.3% | 192 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00↓100.0% | 37↑143.1% | 15 | |
| Free Cash Flow | -48↑45.4% | -89↑40.0% | -148↓7.0% | -138↓179.2% | 175 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.